AR039901A1 - Metabolito a partir de 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol - Google Patents
Metabolito a partir de 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-olInfo
- Publication number
- AR039901A1 AR039901A1 ARP030101885A ARP030101885A AR039901A1 AR 039901 A1 AR039901 A1 AR 039901A1 AR P030101885 A ARP030101885 A AR P030101885A AR P030101885 A ARP030101885 A AR P030101885A AR 039901 A1 AR039901 A1 AR 039901A1
- Authority
- AR
- Argentina
- Prior art keywords
- pentan
- metabolite
- phenyl
- methyl
- metoxi
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/68—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/72—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with quaternised amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
- C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07C215/62—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
- C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
- C07C217/72—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Metabolito a partir de 1-dimetilamino-3(3-metoxi-fenil)-2-metil-pentan-3-ol seleccionado entre fórmulas 1 a 20 en donde, según el caso en forma de sus racematos, sus estereoisómeros puros, en especial enantiómeros o diastereómeros, o en forma de mezclas de estereoisómeros, en especial de enantiómeros o diastereómeros, en cualquier relación de mezcla; en forma pura o en forma de sus ácidos o de sus bases, o en forma de sus sales, en especial las sales fisiológicamente admisibles, o en forma de sus solvatos, en especial de los hidratos. Uso de dichos metabolitos para preparar medicamentos y dichos medicamentos de aplicación en el tratamiento del impulso aumentado de orinar o de la incontinencia urinaria.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10224624A DE10224624A1 (de) | 2002-05-30 | 2002-05-30 | Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol |
Publications (1)
Publication Number | Publication Date |
---|---|
AR039901A1 true AR039901A1 (es) | 2005-03-09 |
Family
ID=29432607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030101885A AR039901A1 (es) | 2002-05-30 | 2003-05-29 | Metabolito a partir de 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1507521A1 (es) |
AR (1) | AR039901A1 (es) |
AU (1) | AU2003238398A1 (es) |
DE (1) | DE10224624A1 (es) |
PE (1) | PE20040521A1 (es) |
WO (1) | WO2003101440A1 (es) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2901180A1 (de) * | 1979-01-13 | 1980-07-24 | Basf Ag | Hexahydro-1,4-oxazepine, verfahren zu deren herstellung und diese enthaltende arzneimittel |
DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
DE19609847A1 (de) * | 1996-03-13 | 1997-09-18 | Gruenenthal Gmbh | Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe |
PE20010623A1 (es) * | 1999-10-05 | 2001-07-07 | Gruenenthal Chemie | Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria |
DE10059412A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz |
-
2002
- 2002-05-30 DE DE10224624A patent/DE10224624A1/de not_active Withdrawn
-
2003
- 2003-05-26 EP EP03732465A patent/EP1507521A1/de not_active Withdrawn
- 2003-05-26 WO PCT/EP2003/005490 patent/WO2003101440A1/de not_active Application Discontinuation
- 2003-05-26 AU AU2003238398A patent/AU2003238398A1/en not_active Abandoned
- 2003-05-27 PE PE2003000510A patent/PE20040521A1/es not_active Application Discontinuation
- 2003-05-29 AR ARP030101885A patent/AR039901A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003101440A1 (de) | 2003-12-11 |
DE10224624A1 (de) | 2003-12-11 |
PE20040521A1 (es) | 2004-08-24 |
AU2003238398A1 (en) | 2003-12-19 |
EP1507521A1 (de) | 2005-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP055738A (es) | PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL | |
ES2486866T3 (es) | Dispositivo ortopédico para corregir posiciones defectuosas de los dedos del pie | |
UY28514A1 (es) | Nuevos compuestos | |
ECSP045491A (es) | Nueva sal formiato de o-desmetil venlafaxina | |
UY27446A1 (es) | Nuevos compuestos | |
AR042437A1 (es) | Derivados de fluoroglicosidos heterociclicos, medicamentos que los contienen y usos | |
AR042097A1 (es) | Uso de de eritropoyetina para el tratamiento de los trastornos de l a distribucion de hierro en las enfermedades cardiacas | |
UY27427A1 (es) | Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos | |
SE0302487D0 (sv) | Novel compounds | |
PA8545301A1 (es) | Nuevos derivados de quinolina | |
SV2002000342A (es) | Inhibidor de la glucogeno fosforilasa ref. pc.10753/20151/bb | |
ES2421744T3 (es) | Válvula cardíaca reposicionable | |
DE602005026945D1 (de) | Expandierbares Medizinprodukt zur Abgabe eines Heilmittels | |
UY28510A1 (es) | Compuestos quimicos | |
UY28348A1 (es) | Compuestos novedosos | |
ECSP045081A (es) | Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados | |
CR7042A (es) | Indanil aminas aciladas y su uso como farmacos | |
HRP20050439B1 (en) | New use of dextran sulfate | |
AR024998A1 (es) | Nuevos retinoides para el tratamiento del enfisema | |
UY27700A1 (es) | Compuestos oxo - azabiclícos. | |
AR044453A1 (es) | Derivados de metoxi-pirazin-tienil sulfonamida | |
AR041339A1 (es) | Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen | |
AR041865A1 (es) | Derivados terapeuticos de prolina y su uso en el tratamiento de epilepsia y dolor | |
AR039901A1 (es) | Metabolito a partir de 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol | |
AR025351A1 (es) | Agonistas retinoides selectivos par |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |